Georgia Center for Diabetes Translation Research

概述：项目摘要/摘要 虽然有相当多的证据可用于预防和治疗糖尿病，但在公平和公平方面仍然存在巨大差距。 并可持续地将这些知识转化为临床和社区环境中的实践和政策。至 为了缩小这些差距，佐治亚州糖尿病翻译研究中心(GCDTR)利用 通过汇聚研究人员之间的合作，在亚特兰大获得多学科专业知识和经验 来自几个领先的机构，即埃默里的罗林斯公共卫生学院、医学院、学校 护理学院、Goizueta商学院、佐治亚理工学院和莫尔豪斯商学院 医学。成功扩大翻译研究(从每年1500万美元增加到3300万美元)，以及 研究人员(从38人到102人，包括26名新招聘的糖尿病教员)基地，GCDTR将 拥抱公平的愿景，努力缩小整个人口群体在糖尿病预防和护理方面的差距 和共病群体，特别是在社会、经济和种族弱势群体中。GCDTR 将包括一个行政核心A，无缝协调三个相互关联的翻译研究核心： (1)核心B，股权设计和评估，强调衡量和借鉴 经验-包括成功和失败-通过适当的衡量标准、评估和创新 有助于促进进步的未来(设计)；(2)促进公平的核心C，社会生态和行为科学， 在开发基于理论的干预措施方面带来丰富的跨学科经验 创新的、技术驱动的参与方法，促进采用和维护健康- 促进弱势群体的行为；和(3)区域核心，技术进步 翻译和股权，并扩大合作伙伴关系，将邻近佛罗里达州和田纳西州的机构包括在内 -东南部各州历史上有大片服务不足的地区和人口患癌症的风险很高 糖尿病。丰富和试点方案以及可行性方案将继续促进年轻人和过渡期 研究人员在翻译研究中竞争NIH资金并对糖尿病产生影响的能力 预防和护理。这个多机构、多学科的中心，涉及120多名成员，带来了 相当广泛和深入的研究专业知识，坚实的研究基础，并利用几个 NIH资助的中心，即佐治亚州临床和翻译科学联盟(GaCTSA)， 艾滋病研究(CFAR)，以及AHA资助的莫尔豪斯/埃默里健康公平中心。靠近和 与美国疾病控制和预防中心糖尿病翻译部的关系 美国疾病控制与预防中心(CDC)还为GCDTR提供了许多独特的资产。此外，我们还进行了几项创新， 获得强有力的机构支持和承诺(5年内总计857,500美元)，并利用 各种博士和博士后项目，以发展一个高效、有效和综合的中心。

OVERVIEW: PROJECT SUMMARY / ABSTRACT While considerable evidence is available for prevention and care of diabetes, huge gaps remain in equitable and sustainable translation of this knowledge into practice and policy in clinical and community settings. To close these gaps, the Georgia Center for Diabetes Translation Research (GCDTR), has leveraged the multidisciplinary expertise and experience in Atlanta, by bringing together collaborations among researchers from several leading institutions, namely, Emory's Rollins School of Public Health, School of Medicine, School of Nursing, and Goizueta Business School; Georgia Institute of Technology; and Morehouse School of Medicine. Having successfully expanded the translation research (from $15 to $33 million annually), and investigators (from 38 to 102 members, including 26 newly recruited diabetes faculty) bases, GCDTR will embrace the vision of equity and strive to close the gaps in diabetes prevention and care across demographic and comorbid groups, especially in socially, economically, and ethnically disadvantaged populations. GCDTR will include an Administrative Core A, seamlessly coordinating three interconnected translation research cores: (1) Core B, Design and Evaluation for Equity, emphasizing measurement and learning from previous experiences—both successes and failures—through appropriate metrics and evaluation and innovating for the future (design) to help stimulate progress; (2) Core C, Socio-ecological and Behavioral Sciences for Equity, bringing a wealth of interdisciplinary experiences in developing theoretically-based interventions and innovative, technology-driven engagement methodologies promoting the adoption and maintenance of health- promoting behaviors among vulnerable populations; and (3) a Regional Core, Technologies Advancing Translation and Equity, and expanding partnerships to include institution in neighboring Florida and Tennessee – southeastern states that have historically had large underserved areas and populations at high risk for diabetes. Enrichment and Pilot and Feasibility Programs will continue to enhance young and transitioning investigators' capacity to be competitive for NIH funds in translation research and have impact on diabetes prevention and care. This multi-institutional, multidisciplinary center, involving over 120 members, brings considerable breadth and depth of research expertise, a substantial research base, and leverages several NIH-funded Centers, namely, the Georgia Clinical and Translational Science Alliance (GaCTSA), Center for AIDS Research (CFAR), and the AHA-funded Morehouse/Emory Center for Health Equity. Proximity to and relationships with the Division of Diabetes Translation at the US Centers for Disease Control and Prevention (CDC) also offers GCDTR many unique assets. Furthermore, we have instituted several innovations, and obtained strong institutional support and commitments (totaling $857,500 over 5 years), and leveraged a variety of doctoral and post-doctoral programs to develop an efficient, effective, and integrated center.